1.四川省南充市中医医院肛肠科(四川 南充 637000)
2.四川省南充市中医医院骨科(四川 南充 637000)
3.川北医学院附属医院肛肠科(四川 南充 637000)
范艺缤,男,硕士,副主任医师,主要从事肛肠疾病的中西医结合基础与临床研究工作
唐学贵,主任医师;E-mail:txg668nc@sohu.com
扫 描 看 全 文
范艺缤, 范小春, 吴至久, 等. 调脏舒秘方治疗慢性便秘(虚证)的临床观察[J]. 上海中医药杂志, 2021,55(2):59-62.
Yibin FAN, Xiaochun FAN, Zhijiu WU, et al. Clinical observation on Tiaozang Shumi Decoction in the treatment of chronic constipation (deficiency syndrome)[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(2):59-62.
范艺缤, 范小春, 吴至久, 等. 调脏舒秘方治疗慢性便秘(虚证)的临床观察[J]. 上海中医药杂志, 2021,55(2):59-62. DOI: 10.16305/j.1007-1334.2021.2008122.
Yibin FAN, Xiaochun FAN, Zhijiu WU, et al. Clinical observation on Tiaozang Shumi Decoction in the treatment of chronic constipation (deficiency syndrome)[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(2):59-62. DOI: 10.16305/j.1007-1334.2021.2008122.
目的,2,观察调脏舒秘方治疗慢性便秘(虚证)的临床疗效。,方法,2,将254例慢性便秘(虚证)患者随机分为对照组和治疗组,每组127例。对照组予渗透性泻剂(复方聚乙二醇电解质散Ⅳ)治疗,治疗组予调脏舒秘方治疗。两组均连续治疗2周,观察临床疗效,比较便秘主要症状积分、状态-特质焦虑问卷(STAI)评分的变化情况。,结果,2,①治疗组近期疗效、远期疗效均优于对照组(,P,<,0.05)。②治疗后、停药后2周与治疗前组内比较,两组粪便性状、排便费力、每次排便时间、下坠不尽感、排便频率、腹胀评分均降低(,P,<,0.05);停药后2周与治疗后比较,治疗组便秘各症状评分差异无统计学意义(,P,>,0.05),对照组粪便性状、排便费力、排便时间、排便频率、腹胀评分升高(,P,<,0.05)。治疗后、治疗结束后2周组间比较,治疗组便秘各症状评分低于对照组(,P,<,0.05)。③治疗前后组内比较,两组STAI 中的状态焦虑量表(S-AI)、特质焦虑量表(T-AI)评分均降低(,P,<,0.05);组间治疗后比较,治疗组S-AI、T-AI评分低于对照组(,P,<,0.05)。④治疗期间,两组患者均未出现明显的不良反应。,结论,2,与复方聚乙二醇电解质散Ⅳ相比,调脏舒秘方治疗慢性便秘(虚证)疗效满意,能更好地改善患者的临床症状及不良心理情绪,且疗效持久,安全性良好。
Objective,2,To observe the clinical effect of Tiaozang Shumi Decoction in the treatment of chronic constipation of deficiency syndrome.,Methods,2,Totally 254 patients with chronic constipation of deficiency syndrome were randomly divided into control group (,n,=127) and treatment group (,n,=127). Control group was treated with permeable cathartic (Polyethylene Glycol Electrolytes Powder Ⅳ), and treatment group was treated with Tiaozang Shumi Decoction, and the two groups were continuously treated for 2 weeks. The clinical effect was observed, and scores of the main constipation symptoms and State-Trait Anxiety Inventory (STAI) were compared.,Results,2,①The short-term and long-term effects in the treatment group were superior to those in the control group (,P,<,0.05). ②After treatment and 2 weeks after drug withdrawal, the scores of fecal characteristics, laborious defecation, defecation time, straining at stool and decreased force of urination, defecation frequency and abdominal distension in the two groups were all lower than those before treatment (,P,<,0.05). There were no significant differences in the scores of constipation symptoms in the treatment group 2 weeks after drug withdrawal compared with those after treatment (,P,>,0.05), and the scores of fecal characteristics, laborious defecation, defecation time, straining at stool and decreased force of urination, defecation frequency and abdominal distension in the control group increased (,P,<,0.05). After treatment and 2 weeks after treatment, the scores of constipation symptoms in the treatment group were lower than those in the control group (,P,<,0.05). ③The scores of State Anxiety Inventory (S-AI) and Trait Anxiety Inventory (T-AI) of STAI decreased in both groups after treatment (,P,<,0.05). The scores of S-AI and T-AI in the treatment group were lower than those in the control group after treatment (,P,<,0.05). ④During the treatment, no obvious adverse reactions occurred in both groups.,Conclusion,2,Compared with Polyethylene Glycol Electrolytes Powder Ⅳ, Tiaozang Shumi Decoction has a more satisfactory therapeutic effect on chronic constipation of deficiency syndrome, and it can better improve the clinical symptoms and adverse psychological emotions of patients with lasting effect and good safety.
慢性便秘虚证调脏舒秘方焦虑抑郁
chronic constipationdeficiency syndromeTiaozang Shumi Decoctionanxietydepression
王佩佩,罗雯,禹铮,等.慢性便秘的研究进展[J].中国全科医学,2017,20(3): 370-374.
顾志坚,林江.便秘常用中药作用机制研究进展[J].上海中医药杂志,2018,52(5): 87-93.
朱元民.葸醌类泻药与大肠黑变病[J].中华消化杂志,2004,24(5): 314-315.
孙健,梁宏涛,陆金根.陆金根治疗出口梗阻型便秘经验[J].上海中医药杂志,2019,53(12): 17-20.
范艺缤,吴至久,魏照洲.调脏舒秘汤对慢传输型便秘大鼠结肠推进率和微管相关蛋白2表达影响的实验研究[J].中医药临床杂志,2016,28(9): 1263-1266.
中华医学会消化病学分会胃肠动力学组,中华医学会外科学分会结直肠肛门外科学组.中国慢性便秘诊治指南(2013,武汉)[J].胃肠病学,2013,18(10): 605-612.
中华中医药学会脾胃病分会.慢性便秘中医诊疗共识意见[J].北京中医药,2011,30(1): 3-7.
中华医学会外科学分会肛肠外科学组.便秘症状及疗效评估[J].中华胃肠外科杂志,2005,8(4): 355.
肖曼曼,刘爱书.特质—状态错失恐惧量表的中文版修订[J].中国临床心理学杂志,2019,27(2): 268-272.
于永铎,尹玲慧,张斯瑶,等.慢传输型便秘伴焦虑抑郁中西医研究进展[J].辽宁中医药大学学报,2019,21(5): 5-8.
亢春.某医院2015-2016年结肠慢传输型便秘患者负性情绪与生活质量现状及二者相关性分析[J].解放军预防医学杂志,2017,35(10): 1317-1319.
乔敬华,何佳伟,周军惠.自拟疏肝通腑汤治疗气滞型功能性便秘的临床疗效观察[J].上海中医药杂志,2018,52(8): 47-49.
倪红辉,吴育,符映均,等.柏子仁及其炮制品对便秘小鼠肠道菌群的影响[J].中医药导报,2020,26(7): 16-19.
赵刚,姜亚欣,迟玉花.白术治疗慢传输型便秘的研究进展[J].青岛大学医学院学报,2017,53(1): 124-126.
陶春虹.枳实对慢传输型便秘大鼠肠神经递质SP、VIP含量的影响[J].中医药信息,2011,28(4): 14-15.
0
浏览量
229
下载量
0
CSCD
3
CNKI被引量
关联资源
相关文章
相关作者
相关机构